These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25670820)

  • 1. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
    Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies.
    Ferrannini G; Tuomilehto J; De Backer G; Kotseva K; Mellbin L; Schnell O; Wood D; De Bacquer D; Rydén L
    Lancet Diabetes Endocrinol; 2024 Nov; 12(11):790-798. PubMed ID: 39326426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
    Ferrannini G; De Bacquer D; Gyberg V; De Backer G; Kotseva K; Mellbin LG; Risebrink R; Tuomilehto J; Wood D; Rydén L
    Diabetes Res Clin Pract; 2022 Jan; 183():109156. PubMed ID: 34843858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA
    Shahim B; De Bacquer D; De Backer G; Gyberg V; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L
    Diabetes Care; 2017 Sep; 40(9):1233-1240. PubMed ID: 28637653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
    Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
    PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.
    Bartnik M; Rydén L; Malmberg K; Ohrvik J; Pyörälä K; Standl E; Ferrari R; Simoons M; Soler-Soler J;
    Heart; 2007 Jan; 93(1):72-7. PubMed ID: 16905628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography.
    Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Lee WL; Liang KW; Sheu WH
    Clin Chem Lab Med; 2015 Aug; 53(9):1441-9. PubMed ID: 25405720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.
    Woerle HJ; Pimenta WP; Meyer C; Gosmanov NR; Szoke E; Szombathy T; Mitrakou A; Gerich JE
    Arch Intern Med; 2004 Aug 9-23; 164(15):1627-32. PubMed ID: 15302632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
    Kengne AP; Erasmus RT; Levitt NS; Matsha TE
    Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration.
    Karnchanasorn R; Huang J; Ou HY; Feng W; Chuang LM; Chiu KC; Samoa R
    J Diabetes Res; 2016; 2016():6195494. PubMed ID: 27597979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population.
    Li C; Yang H; Tong G; Shen S; Feng W; Bi Y; Zhu D
    Acta Diabetol; 2014 Aug; 51(4):601-8. PubMed ID: 24595519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
    Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
    Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.